Nutropin aq and Hypernatraemia - a phase IV clinical study of FDA data

Summary:

Hypernatraemia is reported as a side effect among people who take Nutropin aq (somatropin recombinant), especially for people who are male, 0-1 old, have been taking the drug for < 1 month also take Ddavp, and have Hypopituitarism.

The phase IV clinical study analyzes which people have Hypernatraemia when taking Nutropin aq. It is created by eHealthMe based on reports of 5,621 people who have side effects when taking Nutropin aq from the FDA, and is updated regularly.

What is Nutropin aq?

Nutropin aq has active ingredients of somatropin recombinant. eHealthMe is studying from 5,663 Nutropin aq users. Check the latest studies of Nutropin aq.

What is Hypernatraemia?

Hypernatraemia (an abnormally high plasma concentration of sodium ions) is found to be associated with 655 drugs and 805 conditions by eHealthMe. Check the latest studies of Hypernatraemia.

On Jul, 13, 2026

5,621 people reported to have side effects when taking Nutropin aq.
Among them, 13 people (0.23%) have Hypernatraemia.

Among these 13 people:

How long have people been on Nutropin aq when they have Hypernatraemia? *

What is the gender of people who have Hypernatraemia when taking Nutropin aq? *

female: 23.08 %
male: 76.92 %

What is the age of people who have Hypernatraemia when taking Nutropin aq? *

What are other drugs people take besides Nutropin aq? *

What are other side effects people have besides Hypernatraemia? *

Fever: 9 people, 69.23%
Constipation: 7 people, 53.85%
Upper Respiratory Tract Infection: 7 people, 53.85%
Haematochezia (passage of stools containing blood): 6 people, 46.15%
Developmental Delay: 6 people, 46.15%
Limb Asymmetry (consistent task discrepancy between the two lower limbs): 6 people, 46.15%
Growth Retardation (delayed growth): 6 people, 46.15%
Sinusitis (inflammation of sinus): 6 people, 46.15%
Swallowing Difficulty: 6 people, 46.15%
Hyperacusis (disorder in loudness perception): 6 people, 46.15%

What are the existing conditions these people have? *

Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 12 people, 92.31%
Constipation: 6 people, 46.15%
Growth Hormone Deficiency: 5 people, 38.46%
Stress And Anxiety: 2 people, 15.38%
Hypotension (abnormally low blood pressure): 2 people, 15.38%
Chronic Kidney Disease: 2 people, 15.38%
Anaemia (lack of blood): 2 people, 15.38%
Rashes (redness): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Nutropin aq and have Hypernatraemia?

- Check whether Hypernatraemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nutropin aq:

Nutropin aq (5,663 reports)

Hypernatraemia treatments and more:

Hypernatraemia (6,339 reports)

Browse all side effects of Nutropin aq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypernatraemia:

Hypernatraemia (655 drugs)

Browse all the conditions that are associated with Hypernatraemia:

Hypernatraemia (805 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on somatropin recombinant (the active ingredients of Nutropin aq) and Nutropin aq (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.